Azzalure Botox is indicated for the temporary improvement in the appearance of moderate to severe:
• Glabellar lines (vertical lines between the eyebrows) seen at maximum frown and/or
• Lateral canthal lines (crow’s feet lines) seen at maximum smile
in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.
Posology and method of administration
Posology: Botulinum toxin units are different depending on the medicinal products. The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin.
Pediatric population: The safety and efficacy of Azzalure in individuals aged up to 18 years have not been established. The use of Azzalure is not recommended in subjects under 18 years.
Method of administration: Azzalure Botox for sale should only be administered by physicians with appropriate qualifications and expertise in this treatment and having the required equipment.
Once reconstituted, Azzalure should only be used to treat a single patient, during a single session.
For instructions on reconstitution of the medicinal product before administration, see section 6.6.
Remove any make-up and disinfect the skin with a local antiseptic.
Intramuscular injections should be performed using a sterile suitable gauge needle.
How does Azzalure® Botulinum work in the body?
An active ingredient called botulinum toxin type A, is derived from Clostridium botulinum, a type of bacteria. The toxins role is to stop nerves from carrying out their normal function. By preventing the release of significant chemicals, muscle contraction is also inhibited. The positive effect is to make muscles between the eyebrows relaxed, diminishing the appearance of vertical frown lines. The effect is only temporary and further treatments can be given every three months.
When will results first start to be visible?
Results will first start to be visible after 3 days.
How long will the result last?
The effect can last for up to four months. The treatment interval depends on the individual patient’s response after assessment. Treatment interval with Azzalure should not be more frequent than every three months.